A Study of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons
- Status
- COMPLETED
- Phase
- PHASE2
Expressive Writing and Adjustment to Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC
- Status
- COMPLETED
- Phase
- PHASE2
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2